Prognostic potential of EphA2 expression in prostate cancer patients

被引：0
|
作者：
Bromby, A. [1 ]
Hart, C. [1 ]
Brown, M. [1 ]
Clarke, N. [1 ]
机构：
[1] Univ Manchester, Genito Urinary Canc Res Grp, Inst Canc Serv, Manchester, Lancs, England
来源：
EUROPEAN JOURNAL OF CANCER | 2016年 / 61卷
关键词：
D O I：
10.1016/S0959-8049(16)61654-4
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
808
引用
收藏
页码：S184 / S185
页数：2
相关论文
共 50 条
  • [1] Serum Exosomal EphA2 is a Prognostic Biomarker in Patients with Pancreatic Cancer
    Wei, Qian
    Li, Ze
    Feng, Honglei
    Ren, Li
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 3675 - 3683
  • [2] EPHA2: A novel target for prostate cancer treatment
    Zeng, G
    Hu, ZQ
    Zhang, SB
    Li, L
    Baldridge, LA
    Kao, CH
    Gardner, TA
    Koch, MO
    Ulbright, TM
    Eble, JN
    Cheng, L
    JOURNAL OF UROLOGY, 2004, 171 (04): : 482 - 482
  • [3] Examining EphA2 expression in Colorectal Cancer
    Lyons, Nicholas
    Hooper, John
    Kryza, Thomas
    Clark, David
    Riddell, Andrew
    BJS-BRITISH JOURNAL OF SURGERY, 2022, 109
  • [4] Overexpression of the EphA2 tyrosine kinase in prostate cancer
    Walker-Daniels, J
    Coffman, K
    Azimi, M
    Rhim, JS
    Bostwick, DG
    Snyder, P
    Kerns, BJ
    Waters, DJ
    Kinch, MS
    PROSTATE, 1999, 41 (04): : 275 - 280
  • [5] EphA2 Expression Is a Key Driver of Migration and Invasion and a Poor Prognostic Marker in Colorectal Cancer
    Dunne, Philip D.
    Dasgupta, Sonali
    Blayney, Jaine K.
    McArt, Darragh G.
    Redmond, Keara L.
    Weir, Jessica-Anne
    Bradley, Conor A.
    Sasazuki, Takehiko
    Shirasawa, Senji
    Wang, Tingting
    Srivastava, Supriya
    Ong, Chee Wee
    Arthur, Ken
    Salto-Tellez, Manuel
    Wilson, Richard H.
    Johnston, Patrick G.
    Van Schaeybroeck, Sandra
    CLINICAL CANCER RESEARCH, 2016, 22 (01) : 230 - 242
  • [6] Elevated Expression of EPHA2 Is Associated With Poor Prognosis After Radical Prostatectomy in Prostate Cancer
    Kurose, Hirofumi
    Ueda, Kosuke
    Kondo, Reiichiro
    Ogasawara, Sachiko
    Kusano, Hironori
    Sanada, Sakiko
    Naito, Yoshiki
    Nakiri, Makoto
    Nishihara, Kiyoaki
    Kakuma, Tatsuyuki
    Akiba, Jun
    Igawa, Tsukasa
    Yano, Hirohisa
    ANTICANCER RESEARCH, 2019, 39 (11) : 6249 - 6257
  • [7] Targeting EphA2 in cancer
    Xiao, Ta
    Xiao, Yuhang
    Wang, Wenxiang
    Tang, Yan Yan
    Xiao, Zhiqiang
    Su, Min
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
  • [8] Targeting EphA2 in cancer
    Ta Xiao
    Yuhang Xiao
    Wenxiang Wang
    Yan Yan Tang
    Zhiqiang Xiao
    Min Su
    Journal of Hematology & Oncology, 13
  • [9] Soluble EphA2 is a potential serum biomarker for lung cancer
    Kondo, Tadanori
    Yumoto, Hiroki
    Usui, Kento
    Kato, Kazunori
    CANCER RESEARCH, 2015, 75
  • [10] The prognostic and therapeutic value of EpHA2 in early colorectal cancer (CRC).
    Dasgupta, Sonali
    Van Schaeybroeck, Sandra
    Dunne, Philip
    McArt, Darragh
    Fenning, Cathy
    Ong, Chee Wee
    Arthur, Ken
    Salto-Tellez, Manuel
    Wilson, Richard H.
    Johnston, Patrick
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345